Core Points - WORK Medical Technology Group LTD has received a determination letter from Nasdaq regarding the delisting of its Class A ordinary shares due to a closing bid price of $0.10 or less for ten consecutive trading days [1][2] - The trading of the Company's Class A ordinary shares will be suspended on October 20, 2025, unless an appeal is filed [2] - The Company plans to appeal the delisting determination by October 16, 2025, which will stay the suspension pending the Panel's decision [3] Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. [5] - The Company develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5] - The products are sold in 34 provincial-level regions in China and in over 30 countries worldwide, with 17 products registered with the U.S. Food and Drug Administration [5] Compliance and Future Actions - The Company is considering all available options to regain compliance with Nasdaq Listing Rules, including the possibility of implementing a reverse share split [4]
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq